Where there is Hope: A Qualitative Study Examining Patients’ Adherence to Multi-Drug Resistant Tuberculosis Treatment in Karakalpakstan, Uzbekistan

by Shona Horter, Beverley Stringer, Jane Greig et al.
BMC Infectious Diseases 2016 16:362 – Published: 28 July 2016

16 pp. 990 kB
Pic 002

Treatment for multi-drug resistant tuberculosis (MDR-TB) is lengthy, has severe side effects, and raises adherence challenges. In the Médecins Sans Frontières (MSF) and Ministry of Health (MoH) programme in Karakalpakstan, Uzbekistan, a region with a high burden of MDR-TB, patient loss from treatment (LFT) remains high despite adherence support strategies. While certain factors associated with LFT have been identified, there is limited understanding of why some patients are able to adhere to treatment while others are not. The authors conducted a qualitative study to explore patients’ experiences with MDR-TB treatment, with the aim of providing insight into the barriers and enablers to treatment-taking to inform future strategies of adherence support.

(Visited 32 times, 1 visits today)
This entry was posted in Essential Medicines, General, Tuberculosis. Bookmark the permalink.